Results of the Canadian morbidity study in end-stage renal disease patients treated by hemodialysis.
Churchill
D N
DN
Department of Medicine, McMaster University Medical School, Hamilton, Ontario, Canada.
D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000401:mortality* / Q000628:therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects / Q000401:mortality*
D011994:Recombinant Proteins; D004921:Erythropoietin